D-1286-2020 Class II Terminated

Recalled by Teva Pharmaceuticals USA — Parsippany, NJ

FDA drug recall D-1286-2020 was initiated by Teva Pharmaceuticals USA on May 22, 2020 and is designated Class II. Reason for recall: Some bottles may contain mixed strengths of the product. The recall status is terminated (terminated May 25, 2021). Affected quantity: 41,348 bottles.

Recall details

Product Type
Drugs
Report Date
Jun 10, 2020
Initiation Date
May 22, 2020
Termination Date
May 25, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
41,348 bottles

Product description

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets ( Mixed Amphetamine Salts Product), 15 mg, 100 count bottles, Rx Only, Teva Pharmaceuticals USA, INC. North Wales, PA 19454, NDC 0555-0777-02

Reason for recall

Some bottles may contain mixed strengths of the product.

Distribution pattern

Nationwide within the United State and Puerto Rico.

Code information

Lot #: 42617008, Exp. date 10/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1286-2020
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1286-2020. Report a data issue: hello@regdatalab.com.